Van Eck Associates Corp Viatris Inc Transaction History
Van Eck Associates Corp
- $77.4 Billion
- Q1 2025
A detailed history of Van Eck Associates Corp transactions in Viatris Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 1,873,726 shares of VTRS stock, worth $16.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,873,726
Previous 1,011,489
85.24%
Holding current value
$16.6 Million
Previous $12.6 Million
29.6%
% of portfolio
0.02%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$822 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$660 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$576 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$545 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.8B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...